Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 7, 2013, Pages 911-921

  Sakai, Norihiko ^a   Tager, Andrew M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Epithelial cells; Extracellular matrix; Fibroblasts; Myofibroblasts; Pulmonary fibrosis

Indexed keywords

ABELSON KINASE; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; CONNECTIVE TISSUE GROWTH FACTOR; LATENCY ASSOCIATED PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; PROTEIN PATCHED 1; REACTIVE OXYGEN METABOLITE; SONIC HEDGEHOG PROTEIN; SURFACTANT PROTEIN C; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL ACTIVATION; CELL DAMAGE; CELL INTERACTION; ENDOPLASMIC RETICULUM STRESS; EPITHELIUM CELL; FIBROBLAST; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; LUNG; LUNG ALVEOLUS; LUNG FIBROSIS; METABOLISM;

ERINACEIDAE;

EPITHELIAL CELLS; FIBROBLASTS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; PULMONARY ALVEOLI; PULMONARY FIBROSIS;

EID: 84877086317     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.03.001     Document Type: Review

References (175)

1. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 2007, 117:524-529.
2. King T.E., Pardo A., Selman M. Idiopathic pulmonary fibrosis. Lancet 2011, 378:1949-1961.
3. Scotton C.J., Chambers R.C. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007, 132:1311-1321.
4. Kuwano K., Kunitake R., Kawasaki M., Nomoto Y., Hagimoto N., Nakanishi Y., Hara N. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1996, 154:477-483.
5. Plataki M., Koutsopoulos A.V., Darivianaki K., Delides G., Siafakas N.M., Bouros D. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005, 127:266-274.
6. Uhal B.D., Joshi I., Hughes W.F., Ramos C., Pardo A., Selman M. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 1998, 275:L1192-L1199.
7. Pardo A., Selman M. Molecular mechanisms of pulmonary fibrosis. Front. Biosci. 2002, 7:d1743-d1761.
8. Seibold M.A., Wise A.L., Speer M.C., Steele M.P., Brown K.K., Loyd J.E., Fingerlin T.E., Zhang W., Gudmundsson G., Groshong S.D., Evans C.M., Garantziotis S., Adler K.B., Dickey B.F., du Bois R.M., Yang I.V., Herron A., Kervitsky D., Talbert J.L., Markin C., Park J., Crews A.L., Slifer S.H., Auerbach S., Roy M.G., Lin J., Hennessy C.E., Schwarz M.I., Schwartz D.A. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011, 364:1503-1512.
9. Hagimoto N., Kuwano K., Miyazaki H., Kunitake R., Fujita M., Kawasaki M., Kaneko Y., Hara N. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 1997, 17:272-278.
10. Matute-Bello G., Wurfel M.M., Lee J.S., Park D.R., Frevert C.W., Madtes D.K., Shapiro S.D., Martin T.R. Essential role of MMP-12 in Fas-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 2007, 37:210-221.
11. Lee C.G., Cho S.J., Kang M.J., Chapoval S.P., Lee P.J., Noble P.W., Yehualaeshet T., Lu B., Flavell R.A., Milbrandt J., Homer R.J., Elias J.A. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J. Exp. Med. 2004, 200:377-389.
12. Sisson T.H., Mendez M., Choi K., Subbotina N., Courey A., Cunningham A., Dave A., Engelhardt J.F., Liu X., White E.S., Thannickal V.J., Moore B.B., Christensen P.J., Simon R.H. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2010, 181:254-263.
13. Kuwano K., Kunitake R., Maeyama T., Hagimoto N., Kawasaki M., Matsuba T., Yoshimi M., Inoshima I., Yoshida K., Hara N. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L316-L325.
14. Nogee L.M., Dunbar A.E., Wert S.E., Askin F., Hamvas A., Whitsett J.A. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 2001, 344:573-579.
15. Thomas A.Q., Lane K., Phillips J., Prince M., Markin C., Speer M., Schwartz D.A., Gaddipati R., Marney A., Johnson J., Roberts R., Haines J., Stahlman M., Loyd J.E. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 2002, 165:1322-1328.
16. Lawson W.E., Crossno P.F., Polosukhin V.V., Roldan J., Cheng D.S., Lane K.B., Blackwell T.R., Xu C., Markin C., Ware L.B., Miller G.G., Loyd J.E., Blackwell T.S. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L1119-L1126.
17. Mulugeta S., Nguyen V., Russo S.J., Muniswamy M., Beers M.F. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am. J. Respir. Cell Mol. Biol. 2005, 32:521-530.
18. Tanjore H., Lawson W.E., Blackwell T.S. Endoplasmic reticulum stress as a pro-fibrotic stimulus. Biochim. Biophys. Acta 2013, 1823:940-947.
19. Morishima Y., Nomura A., Uchida Y., Noguchi Y., Sakamoto T., Ishii Y., Goto Y., Masuyama K., Zhang M.J., Hirano K., Mochizuki M., Ohtsuka M., Sekizawa K. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am. J. Respir. Cell Mol. Biol. 2001, 24:1-11.
20. Khalil N., O'Connor R.N., Flanders K.C., Unruh H. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell Mol. Biol. 1996, 14:131-138.
21. Pan L.H., Yamauchi K., Uzuki M., Nakanishi T., Takigawa M., Inoue H., Sawai T. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur. Respir. J. 2001, 17:1220-1227.
22. Ingham P.W. Localized hedgehog activity controls spatial limits of wingless transcription in the Drosophila embryo. Nature 1993, 366:560-562.
23. Urase K., Mukasa T., Igarashi H., Ishii Y., Yasugi S., Momoi M.Y., Momoi T. Spatial expression of Sonic hedgehog in the lung epithelium during branching morphogenesis. Biochem. Biophys. Res. Commun. 1996, 225:161-166.
24. Lama V., Moore B.B., Christensen P., Toews G.B., Peters-Golden M. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am. J. Respir. Cell Mol. Biol. 2002, 27:752-758.
25. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
26. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGFbeta activation. J. Cell Sci. 2003, 116:217-224.
27. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
28. Feng X.H., Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21:659-693.
29. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
30. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:770-774.
31. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997, 124:2659-2670.
32. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howles P.N., Ding J., Ferguson M.W., Doetschman T. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 1995, 11:409-414.
33. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 2006, 3:413-417.
34. Kenyon N.J., Ward R.W., McGrew G., Last J.A. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 2003, 58:772-777.
35. Sime P.J., Xing Z., Graham F.L., Csaky K.G., Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 1997, 100:768-776.
36. Giri S.N., Hyde D.M., Hollinger M.A. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993, 48:959-966.
37. Bonniaud P., Margetts P.J., Kolb M., Schroeder J.A., Kapoun A.M., Damm D., Murphy A., Chakravarty S., Dugar S., Higgins L., Protter A.A., Gauldie J. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am. J. Respir. Crit. Care Med. 2005, 171:889-898.
38. Nishimura S.L. Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am. J. Pathol. 2009, 175:1362-1370.
39. Hayashi H., Sakai T. Biological significance of local TGF-beta activation in liver diseases. Front. Physiol. 2012, 3:1-11.
40. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
41. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
42. Coward W.R., Saini G., Jenkins G. The pathogenesis of idiopathic pulmonary fibrosis. Ther. Adv. Respir. Dis. 2010, 4:367-388.
43. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., Pittet J.F., Kaminski N., Garat C., Matthay M.A., Rifkin D.B., Sheppard D. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328.
44. Puthawala K., Hadjiangelis N., Jacoby S.C., Bayongan E., Zhao Z., Yang Z., Devitt M.L., Horan G.S., Weinreb P.H., Lukashev M.E., Violette S.M., Grant K.S., Colarossi C., Formenti S.C., Munger J.S. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 2008, 177:82-90.
45. Horan G.S., Wood S., Ona V., Li D.J., Lukashev M.E., Weinreb P.H., Simon K.J., Hahm K., Allaire N.E., Rinaldi N.J., Goyal J., Feghali-Bostwick C.A., Matteson E.L., O'Hara C., Lafyatis R., Davis G.S., Huang X., Sheppard D., Violette S.M. Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am. J. Respir. Crit. Care Med. 2008, 177:56-65.
46. Aluwihare P., Munger J.S. What the lung has taught us about latent TGF-beta activation. Am. J. Respir. Cell Mol. Biol. 2008, 39:499-502.
47. Wang A., Yokosaki Y., Ferrando R., Balmes J., Sheppard D. Differential regulation of airway epithelial integrins by growth factors. Am J Respir Cell Mol Biol 1996, 15:664-672.
48. Bates R.C., Bellovin D.I., Brown C., Maynard E., Wu B., Kawakatsu H., Sheppard D., Oettgen P., Mercurio A.M. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Invest. 2005, 115:339-347.
49. Araya J., Cambier S., Markovics J.A., Wolters P., Jablons D., Hill A., Finkbeiner W., Jones K., Broaddus V.C., Sheppard D., Barzcak A., Xiao Y., Erle D.J., Nishimura S.L. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J. Clin. Invest. 2007, 117:3551-3562.
50. Santibanez J.F., Quintanilla M., Bernabeu C. TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.) 2011, 121:233-251.
51. Castelino F.V., Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res. Ther. 2010, 12:213.
52. Zhao J., Shi W., Wang Y.L., Chen H., Bringas P., Datto M.B., Frederick J.P., Wang X.F., Warburton D. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L585-L593.
53. Bhattacharyya S., Wu M., Fang F., Tourtellotte W., Feghali-Bostwick C., Varga J. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. Matrix Biol. 2011, 30:235-242.
54. Daniels C.E., Wilkes M.C., Edens M., Kottom T.J., Murphy S.J., Limper A.H., Leof E.B. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 2004, 114:1308-1316.
55. Daniels C.E., Lasky J.A., Limper A.H., Mieras K., Gabor E., Schroeder D.R. Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results. Am. J. Respir. Crit. Care Med. 2010, 181:604-610.
56. Hu Y., Peng J., Feng D., Chu L., Li X., Jin Z., Lin Z., Zeng Q. Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung 2006, 184:33-42.
57. Caraci F., Gili E., Calafiore M., Failla M., La Rosa C., Crimi N., Sortino M.A., Nicoletti F., Copani A., Vancheri C. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol. Res. 2008, 57:274-282.
58. Horowitz J.C., Lee D.Y., Waghray M., Keshamouni V.G., Thomas P.E., Zhang H., Cui Z., Thannickal V.J. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J. Biol. Chem. 2004, 279:1359-1367.
59. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 1993, 327:125-130.
60. Shi-Wen X., Leask A., Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008, 19:133-144.
61. Gressner O.A., Gressner A.M. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 2008, 28:1065-1079.
62. Grotendorst G.R., Okochi H., Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 1996, 7:469-480.
63. Blom I.E., Goldschmeding R., Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?. Matrix Biol. 2002, 21:473-482.
64. Holmes A., Abraham D.J., Sa S., Shiwen X., Black C.M., Leask A. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem. 2001, 276:10594-10601.
65. Holmes A., Abraham D.J., Chen Y., Denton C., Shi-wen X., Black C.M., Leask A. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J. Biol. Chem. 2003, 278:41728-41733.
66. Muehlich S., Cicha I., Garlichs C.D., Krueger B., Posern G., Goppelt-Struebe M. Actin-dependent regulation of connective tissue growth factor. Am. J. Physiol. Cell Physiol. 2007, 292:C1732-C1738.
67. Leivonen S.K., Hakkinen L., Liu D., Kahari V.M. Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts. J. Invest. Dermatol. 2005, 124:1162-1169.
68. Chen Y., Blom I.E., Sa S., Goldschmeding R., Abraham D.J., Leask A. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 2002, 62:1149-1159.
69. Howell D.C., Johns R.H., Lasky J.A., Shan B., Scotton C.J., Laurent G.J., Chambers R.C. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am. J. Pathol. 2005, 166:1353-1365.
70. Hocher B., Schwarz A., Fagan K.A., Thone-Reineke C., El-Hag K., Kusserow H., Elitok S., Bauer C., Neumayer H.H., Rodman D.M., Theuring F. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am. J. Respir. Cell Mol. Biol. 2000, 23:19-26.
71. Tager A.M., LaCamera P., Shea B.S., Campanella G.S., Selman M., Zhao Z., Polosukhin V., Wain J., Karimi-Shah B.A., Kim N.D., Hart W.K., Pardo A., Blackwell T.S., Xu Y., Chun J., Luster A.D. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 2008, 14:45-54.
72. Villar J., Cabrera N.E., Valladares F., Casula M., Flores C., Blanch L., Quilez M.E., Santana-Rodriguez N., Kacmarek R.M., Slutsky A.S. Activation of the Wnt/beta-catenin signaling pathway by mechanical ventilation is associated with ventilator-induced pulmonary fibrosis in healthy lungs. PLoS One 2011, 6:e23914.
73. Bradham D.M., Igarashi A., Potter R.L., Grotendorst G.R. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 1991, 114:1285-1294.
74. Leask A., Abraham D.J. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 2006, 119:4803-4810.
75. Ball D.K., Moussad E.E., Rageh M.A., Kemper S.A., Brigstock D.R. Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero. Reproduction 2003, 125:271-284.
76. Ball D.K., Rachfal A.W., Kemper S.A., Brigstock D.R. The heparin-binding 10kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J. Endocrinol. 2003, 176:R1-R7.
77. Chen C.C., Chen N., Lau L.F. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J. Biol. Chem. 2001, 276:10443-10452.
78. Brigstock D.R., Steffen C.L., Kim G.Y., Vegunta R.K., Diehl J.R., Harding P.A. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J. Biol. Chem. 1997, 272:20275-20282.
79. Blalock T.D., Gibson D.J., Duncan M.R., Tuli S.S., Grotendorst G.R., Schultz G.S. A connective tissue growth factor signaling receptor in corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2012, 53:3387-3394.
80. Bogatkevich G.S., Ludwicka-Bradley A., Singleton C.B., Bethard J.R., Silver R.M. Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L603-L611.
81. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 2002, 4:599-604.
82. Grotendorst G.R., Duncan M.R. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 2005, 19:729-738.
83. Shi-wen X., Stanton L.A., Kennedy L., Pala D., Chen Y., Howat S.L., Renzoni E.A., Carter D.E., Bou-Gharios G., Stratton R.J., Pearson J.D., Beier F., Lyons K.M., Black C.M., Abraham D.J., Leask A. CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J. Biol. Chem. 2006, 281:10715-10726.
84. Kolb M., Bonniaud P., Galt T., Sime P.J., Kelly M.M., Margetts P.J., Gauldie J. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am. J. Respir. Cell Mol. Biol. 2002, 27:141-150.
85. Bonniaud P., Martin G., Margetts P.J., Ask K., Robertson J., Gauldie J., Kolb M. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am. J. Respir. Cell Mol. Biol. 2004, 31:510-516.
86. Wu S., Platteau A., Chen S., McNamara G., Whitsett J., Bancalari E. Conditional overexpression of connective tissue growth factor disrupts postnatal lung development. Am. J. Respir. Cell Mol. Biol. 2010, 42:552-563.
87. Wang Q., Usinger W., Nichols B., Gray J., Xu L., Seeley T.W., Brenner M., Guo G., Zhang W., Oliver N., Lin A., Yeowell D. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis Tissue Repair 2011, 4:4.
88. Ponticos M., Holmes A.M., Shi-wen X., Leoni P., Khan K., Rajkumar V.S., Hoyles R.K., Bou-Gharios G., Black C.M., Denton C.P., Abraham D.J., Leask A., Lindahl G.E. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum. 2009, 60:2142-2155.
89. Wang X., Wu G., Gou L., Liu Z., Fan X., Wu L., Liu N. A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice. Respirology 2011, 16:500-507.
90. Studer S.M., Kaminski N. Towards systems biology of human pulmonary fibrosis. Proc. Am. Thorac. Soc. 2007, 4:85-91.
91. Selman M., Pardo A., Kaminski N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?. PLoS Med. 2008, 5:e62.
92. Ingham P.W. Hedgehog signaling. Cold Spring Harb. Perspect. Biol. 2012, 4.
93. Ingham P.W., Nakano Y., Seger C. Mechanisms and functions of Hedgehog signalling across the metazoa. Nat. Rev. Genet. 2011, 12:393-406.
94. Weaver M., Batts L., Hogan B.L. Tissue interactions pattern the mesenchyme of the embryonic mouse lung. Dev. Biol. 2003, 258:169-184.
95. Shannon J.M., Hyatt B.A. Epithelial-mesenchymal interactions in the developing lung. Annu. Rev. Physiol. 2004, 66:625-645.
96. Bellusci S., Furuta Y., Rush M.G., Henderson R., Winnier G., Hogan B.L. Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development 1997, 124:53-63.
97. Bellusci S., Henderson R., Winnier G., Oikawa T., Hogan B.L. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 1996, 122:1693-1702.
98. Stewart G.A., Hoyne G.F., Ahmad S.A., Jarman E., Wallace W.A., Harrison D.J., Haslett C., Lamb J.R., Howie S.E. Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes. J. Pathol. 2003, 199:488-495.
99. Coon D.R., Roberts D.J., Loscertales M., Kradin R. Differential epithelial expression of SHH and FOXF1 in usual and nonspecific interstitial pneumonia. Exp. Mol. Pathol. 2006, 80:119-123.
100. Bolanos A.L., Milla C.M., Lira J.C., Ramirez R., Checa M., Barrera L., Garcia-Alvarez J., Carbajal V., Becerril C., Gaxiola M., Pardo A., Selman M. Role of Sonic Hedgehog in idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 303:L978-L990.
101. Cigna N., Farrokhi Moshai E., Brayer S., Marchal-Somme J., Wemeau-Stervinou L., Fabre A., Mal H., Leseche G., Dehoux M., Soler P., Crestani B., Mailleux A.A. The Hedgehog System machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. Am. J. Pathol. 2012, 181:2126-2137.
102. Fitch P.M., Howie S.E., Wallace W.A. Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease. Int. J. Exp. Pathol. 2011, 92:8-17.
103. Maitah M.Y., Ali S., Ahmad A., Gadgeel S., Sarkar F.H. Up-regulation of sonic hedgehog contributes to TGF-beta1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 2011, 6:e16068.
104. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001, 15:3059-3087.
105. Hooper J.E., Scott M.P. Communicating with Hedgehogs. Nat. Rev. Mol. Cell Biol. 2005, 6:306-317.
106. Wilson C.W., Chuang P.T. Mechanism and evolution of cytosolic Hedgehog signal transduction. Development 2010, 137:2079-2094.
107. Moore B.B., Peters-Golden M., Christensen P.J., Lama V., Kuziel W.A., Paine R., Toews G.B. Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L342-L349.
108. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12:1063-1073.
109. Wardlaw S.A., March T.H., Belinsky S.A. Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis 2000, 21:1371-1377.
110. Borok Z., Gillissen A., Buhl R., Hoyt R.F., Hubbard R.C., Ozaki T., Rennard S.I., Crystal R.G. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am. Rev. Respir. Dis. 1991, 144:1080-1084.
111. Bauman K.A., Wettlaufer S.H., Okunishi K., Vannella K.M., Stoolman J.S., Huang S.K., Courey A.J., White E.S., Hogaboam C.M., Simon R.H., Toews G.B., Sisson T.H., Moore B.B., Peters-Golden M. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J. Clin. Invest. 2010, 120:1950-1960.
112. Lee Y.H., Suzuki Y.J., Griffin A.J., Day R.M. Hepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L778-L786.
113. Chapman H.A., Allen C.L., Stone O.L. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis. 1986, 133:437-443.
114. Moore B.B., Paine R., Christensen P.J., Moore T.A., Sitterding S., Ngan R., Wilke C.A., Kuziel W.A., Toews G.B. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol. 2001, 167:4368-4377.
115. Mercer P.F., Johns R.H., Scotton C.J., Krupiczojc M.A., Konigshoff M., Howell D.C., McAnulty R.J., Das A., Thorley A.J., Tetley T.D., Eickelberg O., Chambers R.C. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009, 179:414-425.
116. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 1999, 79:1193-1226.
117. Elias J.A., Rossman M.D., Zurier R.B., Daniele R.P. Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am. Rev. Respir. Dis. 1985, 131:94-99.
118. Bitterman P.B., Wewers M.D., Rennard S.I., Adelberg S., Crystal R.G. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J. Clin. Invest. 1986, 77:700-708.
119. Goldstein R.H., Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J. Biol. Chem. 1982, 257:8630-8633.
120. Kolodsick J.E., Peters-Golden M., Larios J., Toews G.B., Thannickal V.J., Moore B.B. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am. J. Respir. Cell Mol. Biol. 2003, 29:537-544.
121. Moore B.B., Ballinger M.N., White E.S., Green M.E., Herrygers A.B., Wilke C.A., Toews G.B., Peters-Golden M. Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2. J. Immunol. 2005, 174:5644-5649.
122. Huang S.K., Wettlaufer S.H., Chung J., Peters-Golden M. Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1. Am. J. Respir. Cell Mol. Biol. 2008, 39:482-489.
123. Huang S.K., Wettlaufer S.H., Hogaboam C.M., Flaherty K.R., Martinez F.J., Myers J.L., Colby T.V., Travis W.D., Toews G.B., Peters-Golden M. Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2008, 177:66-74.
124. Huang S.K., Fisher A.S., Scruggs A.M., White E.S., Hogaboam C.M., Richardson B.C., Peters-Golden M. Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am. J. Pathol. 2010, 177:2245-2255.
125. Uhal B.D., Joshi I., True A.L., Mundle S., Raza A., Pardo A., Selman M. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am. J. Physiol. 1995, 269:L819-L828.
126. Uhal B.D., Li X., Piasecki C.C., Molina-Molina M. Angiotensin signalling in pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2012, 44:465-468.
127. Wang R., Ramos C., Joshi I., Zagariya A., Pardo A., Selman M., Uhal B.D. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am. J. Physiol. 1999, 277:L1158-L1164.
128. Li X., Zhuang J., Rayford H., Zhang H., Shu R., Uhal B.D. Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA. Curr. Pharm. Des. 2007, 13:1257-1268.
129. Li X., Molina-Molina M., Abdul-Hafez A., Ramirez J., Serrano-Mollar A., Xaubet A., Uhal B.D. Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L887-L895.
130. Abdul-Hafez A., Shu R., Uhal B.D. JunD and HIF-1alpha mediate transcriptional activation of angiotensinogen by TGF-beta1 in human lung fibroblasts. FASEB J. 2009, 23:1655-1662.
131. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 2007, 292:C82-C97.
132. Papp M., Li X., Zhuang J., Wang R., Uhal B.D. Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L713-L718.
133. Wang R., Ibarra-Sunga O., Verlinski L., Pick R., Uhal B.D. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L143-L151.
134. Li X., Rayford H., Uhal B.D. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am. J. Pathol. 2003, 163:2523-2530.
135. Molina-Molina M., Xaubet A., Li X., Abdul-Hafez A., Friderici K., Jernigan K., Fu W., Ding Q., Pereda J., Serrano-Mollar A., Casanova A., Rodriguez-Becerra E., Morell F., Ancochea J., Picado C., Uhal B.D. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression. Eur. Respir. J. 2008, 32:1004-1008.
136. Waghray M., Cui Z., Horowitz J.C., Subramanian I.M., Martinez F.J., Toews G.B., Thannickal V.J. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J. 2005, 19:854-856.
137. Altenhofer S., Kleikers P.W., Radermacher K.A., Scheurer P., Rob Hermans J.J., Schiffers P., Ho H., Wingler K., Schmidt H.H. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell. Mol. Life Sci. 2012, 69:2327-2343.
138. Psathakis K., Mermigkis D., Papatheodorou G., Loukides S., Panagou P., Polychronopoulos V., Siafakas N.M., Bouros D. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur. J. Clin. Invest. 2006, 36:362-367.
139. Maier K., Leuschel L., Costabel U. Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1991, 143:271-274.
140. Lenz A.G., Costabel U., Maier K.L. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur. Respir. J. 1996, 9:307-312.
141. Kuwano K., Nakashima N., Inoshima I., Hagimoto N., Fujita M., Yoshimi M., Maeyama T., Hamada N., Watanabe K., Hara N. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur. Respir. J. 2003, 21:232-240.
142. Barnes J.L., Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 2011, 79:944-956.
143. Takac I., Schroder K., Zhang L., Lardy B., Anilkumar N., Lambeth J.D., Shah A.M., Morel F., Brandes R.P. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 2011, 286:13304-13313.
144. Hecker L., Vittal R., Jones T., Jagirdar R., Luckhardt T.R., Horowitz J.C., Pennathur S., Martinez F.J., Thannickal V.J. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 2009, 15:1077-1081.
145. Geiser T., Ishigaki M., van Leer C., Matthay M.A., Broaddus V.C. H(2)O(2) inhibits alveolar epithelial wound repair in vitro by induction of apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L448-L453.
146. Carnesecchi S., Deffert C., Donati Y., Basset O., Hinz B., Preynat-Seauve O., Guichard C., Arbiser J.L., Banfi B., Pache J.C., Barazzone-Argiroffo C., Krause K.H. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid Redox Signal. 2011, 15:607-619.
147. Tanaka K., Ishihara T., Azuma A., Kudoh S., Ebina M., Nukiwa T., Sugiyama Y., Tasaka Y., Namba T., Sato K., Mizushima Y., Mizushima T. Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L348-L360.
148. Fattman C.L., Chang L.Y., Termin T.A., Petersen L., Enghild J.J., Oury T.D. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic. Biol. Med. 2003, 35:763-771.
149. Hagimoto N., Kuwano K., Inoshima I., Yoshimi M., Nakamura N., Fujita M., Maeyama T., Hara N. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J. Immunol. 2002, 168:6470-6478.
150. Solovyan V.T., Keski-Oja J. Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells. J. Cell. Physiol. 2006, 207:445-453.
151. Li M., Krishnaveni M.S., Li C., Zhou B., Xing Y., Banfalvi A., Li A., Lombardi V., Akbari O., Borok Z., Minoo P. Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 2011, 121:277-287.
152. Zhou Y., Hagood J.S., Lu B., Merryman W.D., Murphy-Ullrich J.E. Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J. Biol. Chem. 2010, 285:22382-22393.
153. Li X., Zhang H., Soledad-Conrad V., Zhuang J., Uhal B.D. Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L501-L507.
154. Konigshoff M., Kramer M., Balsara N., Wilhelm J., Amarie O.V., Jahn A., Rose F., Fink L., Seeger W., Schaefer L., Gunther A., Eickelberg O. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J. Clin. Invest. 2009, 119:772-787.
155. Liu T., Dhanasekaran S.M., Jin H., Hu B., Tomlins S.A., Chinnaiyan A.M., Phan S.H. FIZZ1 stimulation of myofibroblast differentiation. Am. J. Pathol. 2004, 164:1315-1326.
156. Liu T., Hu B., Choi Y.Y., Chung M., Ullenbruch M., Yu H., Lowe J.B., Phan S.H. Notch1 signaling in FIZZ1 induction of myofibroblast differentiation. Am. J. Pathol. 2009, 174:1745-1755.
157. Chung M.J., Liu T., Ullenbruch M., Phan S.H. Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts. J. Pathol. 2007, 212:180-187.
158. Liu T., Baek H.A., Yu H., Lee H.J., Park B.H., Ullenbruch M., Liu J., Nakashima T., Choi Y.Y., Wu G.D., Chung M.J., Phan S.H. FIZZ2/RELM-beta induction and role in pulmonary fibrosis. J. Immunol. 2011, 187:450-461.
159. Schainuck L.I., Striker G.E., Cutler R.E., Benditt E.P. Structural-functional correlations in renal disease. II. The correlations. Hum. Pathol. 1970, 1:631-641.
160. Prunotto M., Budd D.C., Gabbiani G., Meier M., Formentini I., Hartmann G., Pomposiello S., Moll S. Epithelial-mesenchymal crosstalk alteration in kidney fibrosis. J. Pathol. 2012, 228:131-147.
161. Kim S.H., Yu M.A., Ryu E.S., Jang Y.H., Kang D.H. Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease. Lab. Invest. 2012, 92:488-498.
162. Bhaskaran M., Reddy K., Radhakrishanan N., Franki N., Ding G., Singhal P.C. Angiotensin II induces apoptosis in renal proximal tubular cells. Am. J. Physiol. Renal Physiol. 2003, 284:F955-F965.
163. Kim J., Seok Y.M., Jung K.J., Park K.M. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am. J. Physiol. Renal Physiol. 2009, 297:F461-F470.
164. Brezniceanu M.L., Lau C.J., Godin N., Chenier I., Duclos A., Ethier J., Filep J.G., Ingelfinger J.R., Zhang S.L., Chan J.S. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J. Am. Soc. Nephrol. 2010, 21:943-954.
165. Jensen K., Marzioni M., Munshi K., Afroze S., Alpini G., Glaser S. Autocrine regulation of biliary pathology by activated cholangiocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G473-G483.
166. Brenner D.A. Molecular pathogenesis of liver fibrosis. Trans. Am. Clin. Climatol. Assoc. 2009, 120:361-368.
167. Fabris L., Strazzabosco M. Epithelial-mesenchymal interactions in biliary diseases. Semin Liver Dis. 2011, 31:11-32.
168. Popov Y., Patsenker E., Stickel F., Zaks J., Bhaskar K.R., Niedobitek G., Kolb A., Friess H., Schuppan D. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J. Hepatol. 2008, 48:453-464.
169. Wang B., Dolinski B.M., Kikuchi N., Leone D.R., Peters M.G., Weinreb P.H., Violette S.M., Bissell D.M. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology 2007, 46:1404-1412.
170. Kawaguchi Y., Kawanishi H., Mujais S., Topley N., Oreopoulos D.G. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit. Dial. Int. 2000, 20(Suppl. 4):S43-S55.
171. van der Wal J.B., Jeekel J. Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis. 2007, 9(Suppl. 2):9-13.
172. Mizutani M., Ito Y., Mizuno M., Nishimura H., Suzuki Y., Hattori R., Matsukawa Y., Imai M., Oliver N., Goldschmeding R., Aten J., Krediet R.T., Yuzawa Y., Matsuo S. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am. J. Physiol. Renal Physiol. 2010, 298:F721-F733.
173. N. Sakai, J. Chun, J.S. Duffield, T. Wada, A.D. Luster, A.M. Tager, LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation, FASEB J. (in press).
174. Datta A., Scotton C.J., Chambers R.C. Novel therapeutic approaches for pulmonary fibrosis. Br. J. Pharmacol. 2011, 163:141-172.
175. Friedman S.L., Sheppard D., Duffield J.S., Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci. Transl. Med. 2013, 5:167sr1.